Last Updated: July 14, 2026

Patent: 10,189,822

✉ Email this page to a colleague

Summary for Patent: 10,189,822

Title:	Heterocyclic modulators of lipid synthesis
Abstract:	Compounds that are fatty acid synthesis modulators are provided. The compounds may be used to treat disorders characterized by disregulation of the fatty acid synthase function by modulating the function and/or the fatty acid synthase pathway. Methods are provided for treating such disorders including viral infections, such as hepatitis C infection, cancer and metabolic disorders.
Inventor(s):	Oslob; Johan D. (Menlo Park, CA), McDowell; Robert S. (Menlo Park, CA), Johnson; Russell (Menlo Park, CA), Yang; Hanbiao (Menlo Park, CA), Evanchik; Marc (Menlo Park, CA), Zaharia; Cristiana A. (Menlo Park, CA), Cai; Haiying (Menlo Park, CA), Hu; Lily W. (Menlo Park, CA), Duke; Gregory (Menlo Park, CA), Ohol-Gupta; Yamini (Menlo Park, CA), Heuer; Timothy Sean (Menlo Park, CA), O\'Farrell; Marie (Menlo Park, CA)
Assignee:	3-V Biosciences, Inc. (Menlo Park, CA)
Application Number:	15/558,813
Patent Claims:	see list of patent claims

Details for Patent 10,189,822

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	January 10, 1978	⤷ Start Trial	2036-03-15
Genentech, Inc.	AVASTIN	bevacizumab	Injection	125085	February 26, 2004	⤷ Start Trial	2036-03-15
Eli Lilly And Company	CYRAMZA	ramucirumab	Injection	125477	April 21, 2014	⤷ Start Trial	2036-03-15
Merck Sharp & Dohme Llc	KEYTRUDA	pembrolizumab	For Injection	125514	September 04, 2014	⤷ Start Trial	2036-03-15
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.